Thursday, 25 April 2013

Insulin to Account for 32% of the Indian Diabetes Medication Market by 2018

IMARC Group, one of the world’s leading research and advisory firms, expects the total market for insulin in India to grow at a CAGR of 19% during 2013-2018. Findings from its latest report entitled “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics” suggests that by 2018, insulin is expected to account for 32% of the entire diabetes medication market in India. 

According to the report, the market for both oral anti-diabetics and insulin are experiencing robust growth. The report cites increasing sedentary lifestyles, lack of physical activity, obesity, stress and consumption of diets rich in fat, sugar and calories as the catalysts in driving the prevalence of diabetes in India. According to an analyst at IMARC Group,“India’s rapid economic growth in the last few decades has led to a rapid urbanization in the country. Between 1991 and 2011, the proportion of people living in urban India rose from 26% to 31%; a trend that is predicted to increase at a faster pace in the coming years. Increased prosperity has brought an increase in sedentary lifestyles and western diets. As a result, the prevalence of diabetes in the urban regions has been much faster compared to the rural regions”.


IMARC’s new report “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Anti-diabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players. 


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


For more information, visit: http://www.imarcgroup.com/india-diabetes/

Wednesday, 24 April 2013

IMARC Group Looking for Partners to Outsource its Market Research Activities in China & LatinAmerica

The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, chemical products, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Purpose of the Request

IMARC Group is looking forward to expand its presence in the chemical industry space in the regions of China and Latin America, and therefore looking for partners who can help IMARC cater the needs of its clients in these regions. 

The partnering companies are expected to help IMARC in the following matters:

• Primary and Secondary Data Collection 
• Market/Product Assessment Reports
• Company Reports
• Cost Models
• Supply Chain Research
Business Partner Identification
• Customer Identification
• Vendor Identification
• Regulatory Assessment


Qualification Requirements

• Thorough Understanding of the Local Business Environment: The Company is expected to be well versed with local language and culture. Since the projects would relate to the data collection, analysis and study focussed on the region, we would only consider companies that are locally based (China and Latin America).

• Experience: Demonstrated experience of the Company and its staff in the field of market research and consulting (specifically the chemical industry) in the regions of China and Latin America. Experience of having worked with the procurement team of a detergent or personal care organisation would be an added advantage.

• Timely Delivery: IMARC Group values the time of its clients and therefore all projects of IMARC are deadline based. The deadline may vary from a few hours to a few months. The applying company should be able to deliver the project on the deadlines set by IMARC Group. 

• Proven Methodology: The Company is expected to have well established methodology to work on complex and constantly changing knowledge processes in the chemical industry space.


Proposal Submission

Interested companies may send a request to bk.arpan@imarcgroup.com upon which we would send you a form to be filled in. 

We look forward to working with you, and please do not hesitate to contact us if you have any additional questions.


To learn more about our company and the current offering, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


For more information, visit: http://www.imarcgroup.com

Tuesday, 23 April 2013

A New Report Analyzes the Indian Smart Card Industry

In Pugalur - a small village in Tamil Nadu, Swami, a 55 year old farmer goes out to withdraw some money from his bank account. He takes out a smart card from his pocket and gives it to a business correspondent - a bank appointed agent who comes to the village with an electronic handheld device connected to the bank. The business correspondent takes Swami’s smart card and inserts it on his hand held device facilitating withdrawal of his money, deposits and other transactions.

Smart cards have not only changed Swami’s life but also the lives of millions of Indians living in remote villages who previously had no access to any kind of financial services. Be it an identity card, credit card, drivers license, health insurance card or a metro pass; smart cards are not only rapidly replacing paper and magnetic stripe cards wherever they are in use but have also started penetrating into sectors that had remained untapped so far. 


In technology terms, smart cards resemble similar to “dumb” magnetic stripe cards, but with one major difference: embedded in them is a computer chip, either to process data held on the card, or to act as an access key to data that is held remotely. Smart cards are more secure than simple plastic or magnetic stripe cards and are more versatile, being able to store more data and operate multiple applications. 

Till recently, the telecom sector has been the only prominent user of smart cards in the country. The picture is now undergoing a radical change. Driven by a number of public and private initiatives, the use of smart cards is getting more and more diversified. During 2013-2018, we expect smart cards to further percolate into a number of other sectors such as credit/debit cards, financial inclusion, public distribution, healthcare, identity management, transportation, etc. The versatile application of smart cards can be further validated from the fact that the telecom sector, which represented the biggest application sector in 2012, accounted for more than 70% of the total market volumes. In contrast, the National Population Register, which is expected to represent the biggest application segment in 2018, is expected to account for less than 31% of the total market volumes by 2018.

IMARC’s new report entitled “Smart Card Industry in India: SIM, Identity, Banking, Transport, Healthcare, Pay TV, Loyalty & PDS” gives a deep insight into the Indiansmart cards market. The research study serves as an analytical as well as a statistical tool to understand not only the market trends, structure, drivers and restraints but also the outlook of the market till 2018. This report aims to serve as an excellent guide for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the Indian smart cards market in some form or the other.


Table of Contents
1. Research Methodology & Market Definitions
2. Executive Summary
3. Smart Card Industry in India: Market Performance
3.1 Historical & Current Demand
3.2 Historical and Current Demand by Application
3.3 Demand Forecast
3.4 Demand Forecast by Application
4. Smart Card Industry in India: Market by Application
4.1 Telecommunications
4.1.1 Application Overview
4.1.2 Smart Card Sales & Volume: Current Trends & Forecast
4.2 National Population Register
4.2.1 Application Overview
4.2.2 Smart Card Sales & Volume: Current Trends & Forecast
4.3 Public Distribution Systems
4.3.1 Application Overview
4.3.2 Smart Card Sales & Volume: Current Trends & Forecast
4.4 Pay TV
4.4.1 Application Overview
4.4.2 Smart Card Sales & Volume: Current Trends & Forecast
4.5 Loyalty Cards
4.5.1 Application Overview
4.5.2 Smart Card Sales & Volume: Current Trends & Forecast
4.6 Financial Services
4.6.1 Credit/Debit Cards
4.6.1.1 Application Overview
4.6.1.2 Smart Card Sales & Volume: Current Trends & Forecast
4.6.2 Financial Inclusion
4.6.2.1 Application Overview
4.6.2.2 Smart Card Sales & Volume: Current Trends & Forecast
4.6.3 PAN Cards
4.6.3.1 Application Overview
4.6.3.2 Smart Card Sales & Volume: Current Trends & Forecast
4.7 Travel Identity
4.7.1 E-Passports
4.7.1.1 Application Overview
4.7.1.2 Smart Card Sales & Volume: Current Trends & Forecast
4.7.2 Driving License
4.7.2.1 Application Overview
4.7.2.2 Smart Card Sales & Volume: Current Trends & Forecast
4.7.3 Registration Certificates
4.7.3.1 Application Overview
4.7.3.2 Smart Card Sales & Volume: Current Trends & Forecast
4.8 Health Care
4.8.1 Rashtriya Swasthya Bima Yojana
4.8.1.1 Application Overview
4.8.1.2 Smart Card Sales & Volume: Current Trends & Forecast
4.8.2 Other Healthcare Projects.
4.9 Automated Fare Collection
4.9.1 Metro Rail Projects
4.9.1.1 Delhi Metro
4.9.1.2 Kolkata Metro
4.9.1.3 Bangalore Metro
4.9.1.4 Mumbai Metro
4.9.1.5 Hyderabad Metro
4.9.1.6 Chennai Metro
4.9.1.7 Other Metro Projects
4.9.2 Bus Transportation
4.9.2.1Ahmadabad’s Public Bus Transport System
4.9.2.2 Mumbai’s and Navi Mumbai’s Public Bus Transport System
4.9.2.3 Karnataka’s Public Bus Transport System
4.9.2.4 Other Bus Transport Systems
4.9.3 Indian Railways
5. Drivers
5.1 India Provides One of the World’s Largest Consumer Base for Mass Market Applications
5.2 India’s Growing Mobile Subscriber Base Will Continue to Drive Demand in the Telecom Sector
5.3 e-Governance Initiatives to Create a Huge Demand in the Public Sector
5.4 Modernization of Public Transport Systems is Expanding Smartcard Usage
5.5 Identity Management is Creating a Huge Opportunity for Smart Cards
5.6 Retail & Banking Sectors Offer Immense Potential
6. Challenges
6.1 Implementing Smartcard Based Systems Requires Substantial Infrastructure Investments
6.2 Limited Awareness & Resistance to Technological Changes
6.3 Systemic Delays
6.4 Chip Prices Have Been Declining in Recent Years
7. Key Company Profiles


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


For more information, visit: http://www.imarcgroup.com/smart-card-india/

Monday, 22 April 2013

New Report Analyzes the Performance of the Indian Fertilizer Industry

Increasing rural incomes, availability of farm credit, government & non-government awareness campaigns, contact farming, a large untapped market etc. are expected to be the catalysts in driving the Indian Fertilizer market in the coming years. Research firm IMARC Group expects the total market volumes to grow at a CAGR of around 7% during 2013-2017, according to its latest report titled “Indian Agriculture Market Report & Forecast: 2012-2017”. According to an analyst at IMARC Group, “Despite strong historical growth, fertilizer consumption in India remains highly skewed. There are currently a number of states in India which still have a very low penetration of fertilizers. This leaves a lot of room for future growth”. Apart from a large unpenetrated market, findings from the report also suggest that increasing rural incomes coupled by easy availability of credit are also likely to create a positive impact on fertilizer usage in the country. Contract farming, where inputs in terms of technology and training are expected to be provided to the farmer from the food processor (contractor) is also expected to act as a catalyst in increasing the fertilizer usage in the country.

IMARC’s new report entitled “Indian Agriculture Market Report & Forecast: 2012-2017” provides an analytical and statistical insight into the agriculture industry along with its various segments and sub-segments. The study that has been undertaken using both desk-based and qualitative primary research has analyzed various aspects and provides a comprehensive understanding of the Indian agriculture market. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists, and all those who are looking to foray into the Indian agriculture market in some form or the other.


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


Tuesday, 16 April 2013

Transit Media to Account for 45% of the Indian Advertising Market by 2016

IMARC Group, one of the world’s leading research and advisory firms, finds that the total market for transit advertising in India is expected to grow at a CAGR of 22% during 2013-2016. Findings from its latest report entitled “Indian Advertising Market Report & Forecast (2012-2016)” suggests that the total share of transit media in the Indian advertising market is expected to increase from around 33% in 2012 to around 45% by 2016.

According to the report, recent years have witnessed improvements and modernization of the Indian public transport systems such as metro rail, low floor/AC buses, etc. In the coming years, new modes of public transport such as mono rail are also likely to appear in the Indian cities. These developments would lead to the creation of more advertising space. Taking into consideration the amount of time a person spends on travelling everyday in course of his job, business, profession, socializing or entertainment, this medium of advertising is full of growth potential. The central as well as many state governments are planning to either introduce metro rail service or to expand existing networks in various cities in the coming years and these measures are expected to give a big boost to transit advertising.


Apart from the modernization of transport, the booming services sector is also expected to be a major catalyst in driving the growth of the transit media advertising market in India. The services sector currently accounts for a bulk (approx 55%) of the Indian economy. This sector has been growing rapidly and is expected to further expand in the coming years. This would propel growth in the movement of people, both within and between cities and keep on adding to the visibility of transit advertising. It is but natural that advertisers would increasingly prefer this medium of advertising to showcase and highlight their products at airports, bus stops, railway platforms, etc.

IMARC’s new report titled “Indian Advertising Market Report & Forecast: 2012-2016” provides an analytical and statistical insight into the Indian advertising industry along with its various segments and sub-segments. The study that has been undertaken using both desk-based and qualitative primary research has analyzed various aspects and provides a comprehensive understanding of the Indian advertising market. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists, media planners, advertisers, radio and television broadcasters and all those who are planning to foray into the Indian advertising market in some form or the other.

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


For more information, visit: http://www.imarcgroup.com/indian-advertising-market-report-forecast-2012-2016/

Thursday, 11 April 2013

New Report Analyzes the Potential of Therapeutic Monoclonal Antibodies in India

A huge patient pool, increasing prevalence of health insurance, strong biosimilar manufacturing capabilities and a largely unpenetrated market are expected to be the catalysts in driving the market for monoclonal antibodies in India. Research firm IMARC Group expects this market to grow at a CAGR of around 26% during 2013-2016, according to its latest report entitled “Indian Monoclonal Antibodies Market Report & Forecast: 2012-2016”.

According to an analyst at IMARC Group, “India’s poor historical track record in Intellectual property protection has resulted in many Indian companies acquiring strong reverse engineering skills. The Indian generic industry provides generic drugs not only to India but to the entire world. India currently has more FDA approved manufacturing facilities than any other country outside the US. Globally there are only 2 approved biosimilar monoclonal antibodies with Reditux (Rituximab) (developed and manufactured by Dr. Ready’s, an Indian generic manufacturer) being one of them. As a result, India and its biosimilar manufacturers can be regarded as the front runners in the global biosimilar antibody market race”.

Key Aspects Analyzed in this Report:

• Understanding the strengths, weaknesses, opportunities and challenges in the Indian monoclonal antibodies market
• Understanding the technological considerations and regulatory factors in the Indian monoclonal antibodies market
• Evaluation and identification of monoclonal antibodies based on the sources from which they are derived and on the targets against which they act
• Understanding the key regulations for registering, manufacturing and importing monoclonal antibodies in India

• Evaluating the patent details of all globally marketed monoclonal antibodies in India, US and Europe
• Identifying the patentee name and patent numbers of all in-market monoclonal antibodies in India, US and Europe
• Identifying the monoclonal antibodies that are patent protected in India, US and Europe and those that are not
• Estimating the patent expiries of various monoclonal antibodies in India, US and Europe 

• Comprehensive situation analysis of the Indian monoclonal antibodies market
• Analyzing current and future sales of monoclonal antibodies in India
• Identifying all globally launched monoclonal antibodies and understanding their performance and launch status in India
• Analyzing the global and Indian monoclonal antibodies market by Indication
• Evaluation of the top selling monoclonal antibodies
• Key biosimilar antibody development programmes in India and abroad

Table of Contents

1 Market Definitions & Methodology

2 Executive Summary

3 Therapeutic Antibodies Market in India

3.1 Industry Analysis
3.1.1 Strengths
3.1.2 Weaknesses
3.1.3 Opportunities
3.1.4 Threats
3.2 Technological & Regulatory Assessment
3.2.1 Technological Assessment
3.2.2 Regulatory Assessment
3.3 Patent Details of Various Monoclonal Antibodies: US, Europe & India
3.4 Market Analysis
3.4.1 Current & Future Sales Trends
3.4.2 Sales Breakup by Molecule
3.4.3 Sales by Indication
3.5 Evaluation of Top Monoclonal Antibodies
3.5.1.1 Avastin
3.5.1.2 Herceptin
3.5.1.3 Rituxan/Mabthera
3.5.1.4 Remicade
3.5.1.5 Humira
3.6 Biosimilar Case Studies
3.6.1 Reditux
3.6.2 Grafeel
3.7 Key Indian & Foreign Biosimilar Antibody Development Programmes


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331

Wednesday, 10 April 2013

Asia Pacific Healthcare Cold Chain Logistics Market to Grow at a CAGR of 12% During 2013-2017

IMARC Group, one of the world’s leading research and advisory firms, finds that the total market for healthcare cold chain logistic services in the Asia Pacific region is expected to grow at a CAGR of 12% during 2013-2017. Findings from its latest report entitled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2012-2017)” suggests that excluding some of the developed economies such as Japan, Australia and Singapore, most of the countries in the region still have an under developed cold chain infrastructure leaving a lot of room for future growth. According to an analyst at IMARC Group, “The sales of biopharmaceuticals and vaccines in most of these markets are expected to expand rapidly during the forecast period. A number of Asia Pacific destinations such as India, China, Singapore and South Korea etc. are also emerging as major destinations for outsourcing clinical trials, drug manufacturing and pathology testing. Driven by these factors, we expect the cold chain logistics market in the Asia Pacific region to account for nearly 30% of the global market by 2017.”

This report, an updated and far more extensive and analytical version of our popular 2011 study, provides a comprehensive insight into the logistic opportunities in the global healthcare market. The study, that has been undertaken using both desk based and qualitative primary market research, has analyzed three aspects of the global healthcare cold chain logistics market.


The first aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes. The second aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. The third aspect involves the quantification of the global healthcare cold chain logistic services market and a comprehensive evaluation of its various segments.


What we have achieved in this report:

Comprehensive Market Analysis of Temperature Sensitive Healthcare Products:

Classes Covered: Biopharmaceuticals, Vaccines & Clinical Trial Materials 
Focus of the Analysis in Each Class:
• Drivers and challenges 
• Historical sales trends
• Logistic requirements 
• Impact of temperature excursions 
• Opportunities in cold chain services
• Market outlook (2012-2017)


Understanding the Operations of a Healthcare Cold Chain Distribution Process:
Focus of the Analysis:
• Understanding the various methods of cold chain distribution and their advantages/disadvantages
• Understanding the cold chain requirements for various temperature sensitive healthcare products and the impact of temperature excursions
• Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation
• Understanding the key steps required in the setting and organization of an efficient cold chain distribution process


Comprehensive Market Analysis of the Healthcare Cold Chain Logistic Services Market:
Focus of the analysis:
• Quantifying the global healthcare cold chain logistic services market
• Quantifying the market size by product
• Quantifying the market size by service
• Quantifying the market size by region


Information Sources:
Information has been sourced from both primary and secondary sources:
• Primary sources include industry surveys and face to face/telephone interviews with industry experts.
• Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America 
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331


For more information, visit: http://www.imarcgroup.com/global-healthcare-cold-chain-logistics-market-report-forecast-2012-2017/